Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells
Cells · 2024
DOI: 10.3390/cells13100817 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Sandra Jenkner und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide 5000, Australia. Hauptthemen laut MEDLINE: Spinal Cord Injuries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Neil Sachse Centre for Spinal Cord Research, Australian Government Research Training Program (RTP) Stipend, RTP Fee-Offset Scholarship through the University of Adelaide.
Abstract (Originalsprache)
Spinal cord injury (SCI) can result in the permanent loss of mobility, sensation, and autonomic function. Secondary degeneration after SCI both initiates and propagates a hostile microenvironment that is resistant to natural repair mechanisms. Consequently, exogenous stem cells have been investigated as a potential therapy for repairing and recovering damaged cells after SCI and other CNS disorders. This focused review highlights the contributions of mesenchymal (MSCs) and dental stem cells (DSCs) in attenuating various secondary injury sequelae through paracrine and cell-to-cell communication mechanisms following SCI and other types of neurotrauma. These mechanistic events include vascular dysfunction, oxidative stress, excitotoxicity, apoptosis and cell loss, neuroinflammation, and structural deficits. The review of studies that directly compare MSC and DSC capabilities also reveals the superior capabilities of DSC in reducing the effects of secondary injury and promoting a favorable microenvironment conducive to repair and regeneration. This review concludes with a discussion of the current limitations and proposes improvements in the future assessment of stem cell therapy through the reporting of the effects of DSC viability and DSC efficacy in attenuating secondary damage after SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide 5000, Australia.
- Neil Sachse Centre for Spinal Cord Research, Lifelong Health Theme, South Australian Health and Medical Research Institute, North Terrace, Adelaide 5000, Australia.
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide 5000, Australia.
- Mesenchymal Stem Cell Laboratory, Precision Medicine Theme, South Australian Health and Medical Research Institute, North Terrace, Adelaide 5000, Australia.
ORCID-Profile: Stan Gronthos, Ryan Louis O'Hare Doig
Förderung
- Neil Sachse Centre for Spinal Cord Research
- Australian Government Research Training Program (RTP) Stipend
- RTP Fee-Offset Scholarship through the University of Adelaide
- AOSpine Foundation
Zitieren
APA
Jenkner, S., Clark, J. M., Gronthos, S., & O'Hare Doig, R. L. (2024). Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells. Cells. https://doi.org/10.3390/cells13100817
Vancouver
Jenkner S, Clark JM, Gronthos S, O'Hare Doig RL. Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells. Cells. 2024. doi:10.3390/cells13100817
BibTeX
@article{Jenkner2024,
author = {Jenkner, Sandra and Clark, Jillian Mary and Gronthos, Stan and O'Hare Doig, Ryan Louis},
title = {Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13100817}
}
EUVIMED